Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

1.

High-density lipoprotein-raising strategies: update 2010.

Spillmann F, Schultheiss HP, Tschöpe C, Van Linthout S.

Curr Pharm Des. 2010 May;16(13):1517-30. Review.

PMID:
20196737
[PubMed - indexed for MEDLINE]
2.

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM.

Heart. 2008 Jun;94(6):706-14. doi: 10.1136/hrt.2007.125401. Review.

PMID:
18480348
[PubMed - indexed for MEDLINE]
3.

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM.

Postgrad Med J. 2008 Nov;84(997):590-8. doi: 10.1136/hrt.2007.125401. Review.

PMID:
19103817
[PubMed - indexed for MEDLINE]
4.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
[PubMed - indexed for MEDLINE]
5.

Role of fibric acid derivatives in the management of risk factors for coronary heart disease.

Després JP, Lemieux I, Robins SJ.

Drugs. 2004;64(19):2177-98. Review.

PMID:
15456334
[PubMed - indexed for MEDLINE]
6.

Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels.

Hausenloy DJ, Yellon DM.

Curr Opin Cardiol. 2009 Sep;24(5):473-82. doi: 10.1097/HCO.0b013e32832ebfe7. Review.

PMID:
19574922
[PubMed - indexed for MEDLINE]
7.

Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.

Chapman MJ, Assmann G, Fruchart JC, Shepherd J, Sirtori C; European Consensus Panel on HDL-C.

Curr Med Res Opin. 2004 Aug;20(8):1253-68. Review.

PMID:
15324528
[PubMed - indexed for MEDLINE]
8.

Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protection.

Meyers CD, Kashyap ML.

Curr Opin Cardiol. 2004 Jul;19(4):366-73. Review.

PMID:
15218398
[PubMed - indexed for MEDLINE]
9.

Diabetic dyslipidemia.

Kreisberg RA.

Am J Cardiol. 1998 Dec 17;82(12A):67U-73U; discussion 85U-86U. Review.

PMID:
9915665
[PubMed - indexed for MEDLINE]
10.

The antiatherogenic role of high-density lipoprotein cholesterol.

Kwiterovich PO Jr.

Am J Cardiol. 1998 Nov 5;82(9A):13Q-21Q. Review.

PMID:
9819099
[PubMed - indexed for MEDLINE]
11.

High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies.

Toth PP.

Am J Cardiol. 2005 Nov 7;96(9A):50K-58K; discussion 34K-35K. Epub 2005 Sep 15. Review.

PMID:
16291015
[PubMed - indexed for MEDLINE]
12.

Advances in drug treatment of dyslipidemia: focus on atorvastatin.

Davignon J.

Can J Cardiol. 1998 May;14 Suppl B:28B-38B. Review.

PMID:
9627539
[PubMed - indexed for MEDLINE]
14.

The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'.

Devroey D, Velkeniers B, Duquet W, Betz W.

Int J Cardiol. 2005 May 25;101(2):231-5.

PMID:
15882669
[PubMed - indexed for MEDLINE]
15.

Emerging strategies and agents to lower cardiovascular risk by increasing high density lipoprotein cholesterol levels.

Greenfeder S.

Curr Med Chem. 2009;16(2):144-56. Review.

PMID:
19149567
[PubMed - indexed for MEDLINE]
16.

Nicotinic acid and other therapies for raising high-density lipoprotein.

Carlson LA.

Curr Opin Cardiol. 2006 Jul;21(4):336-44. Review.

PMID:
16755203
[PubMed - indexed for MEDLINE]
17.

Therapies to increase high-density lipoprotein cholesterol and their effect on cardiovascular outcomes and regression of atherosclerosis.

Venkatesh PK, Caskey D, Reddy PC.

Am J Med Sci. 2008 Jul;336(1):64-8. doi: 10.1097/MAJ.0b013e31815d4419. Review.

PMID:
18626239
[PubMed - indexed for MEDLINE]
18.

Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?

LaRosa JC.

Womens Health Issues. 1992 Summer;2(2):102-11; discussion 111-3.

PMID:
1617306
[PubMed - indexed for MEDLINE]
19.

Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Hersberger M, von Eckardstein A.

Drugs. 2003;63(18):1907-45. Review.

PMID:
12930163
[PubMed - indexed for MEDLINE]
20.

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

Nesto RW.

Am J Cardiovasc Drugs. 2005;5(6):379-87. Review.

PMID:
16259526
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk